for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol - Dahlof,B.; Devereux,B.; Kjeldsen,S.E. (Lancet, 2002)